JPRN-UMIN000038594已完成未知
A prospective observational study of pembrolizumab and chemotherapy for lung cancer patients with interstitial abnormalities - Pembrolizumab and chemotherapy for lung cancer patients with interstitial abnormalities
Kobe University Graduate School of Medicine0 个研究点目标入组 2 人开始时间: 2019年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with history of drug induced pneumonitis. 2)Patients who has increased infiltration other than lung cancer within 1 month. 3)Patients with interstitial pneumonitis with UIP pattern on computed tomography. 4)Patients with interstitial pneumonitis associated with collagen diseases. 5)Pregnant women and patients who may be pregnant or breastfeeding. 6)Patients who are judged to be inappropriate for the study by the investigator.
研究者
相似试验
招募中
2 期
Clinical trial of combined therapy with pembrolizumab and lenvatinib for patients with classic Kaposi sarcoma treated with at least one previous line of chemioterapy.2024-512834-14-00Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico25
进行中（未招募）
1 期
Study on Pembrolizumab in preneoplastic high grade HPV-related vulvar and cervical lesionsPatients with pre neoplastic high grade HPV-related vulvar and cervical lesionsMedDRA version: 20.0Level: PTClassification code 10054932Term: Vulvar dysplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 20.0Level: PTClassification code 10008263Term: Cervical dysplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2019-002247-23-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE46
已完成
2 期
A single arm confirmatory study of pembrolizumab in patients with previously untreated advanced sarcomatoid carcinoma of the lungJPRN-UMIN000027629Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital22
进行中（未招募）
1 期
PROMO: A phase II study of Pembrolizumab in patients with Relapsed Or Metastatic Osteosarcoma not eligible for curative surgeryEUCTR2016-001676-29-ITOSLO UNIVERSITETSSYKEHUS HF25
进行中（未招募）
1 期
PROMO: A phase II study of Pembrolizumab in patients with Relapsed Or Metastatic Osteosarcoma not eligible for curative surgeryEUCTR2016-001676-29-NOOslo University Hospital (OUS)25